184 related articles for article (PubMed ID: 22693581)
21. Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristics.
Plasseraud KM; Wilkinson JK; Oelschlager KM; Poteet TM; Cook RW; Stone JF; Monzon FA
Diagn Pathol; 2017 Aug; 12(1):59. PubMed ID: 28778171
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development.
Zuidervaart W; van der Velden PA; Hurks MH; van Nieuwpoort FA; Out-Luiting CJ; Singh AD; Frants RR; Jager MJ; Gruis NA
Br J Cancer; 2003 Nov; 89(10):1914-9. PubMed ID: 14612903
[TBL] [Abstract][Full Text] [Related]
23. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
Gangemi R; Mirisola V; Barisione G; Fabbi M; Brizzolara A; Lanza F; Mosci C; Salvi S; Gualco M; Truini M; Angelini G; Boccardo S; Cilli M; Airoldi I; Queirolo P; Jager MJ; Daga A; Pfeffer U; Ferrini S
PLoS One; 2012; 7(1):e29989. PubMed ID: 22267972
[TBL] [Abstract][Full Text] [Related]
24. EMT-associated factors promote invasive properties of uveal melanoma cells.
Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
[TBL] [Abstract][Full Text] [Related]
25. Genomic investigations of posterior uveal melanoma.
Hovland PG; Trempe C
Semin Ophthalmol; 2005; 20(4):231-8. PubMed ID: 16352494
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of Mart-1 in human uveal melanoma cells.
Wang J; Jia R; Yao Y; Cun B; Huang X; Gu P; Ge S; Fan X
Mol Med Rep; 2011; 4(5):799-803. PubMed ID: 21667026
[TBL] [Abstract][Full Text] [Related]
27. Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling.
Worley LA; Long MD; Onken MD; Harbour JW
Melanoma Res; 2008 Jun; 18(3):184-90. PubMed ID: 18477892
[TBL] [Abstract][Full Text] [Related]
28. Role of Genetics and Epigenetics in Mucosal, Uveal, and Cutaneous Melanomagenesis.
Venza M; Visalli M; Beninati C; Biondo C; Teti D; Venza I
Anticancer Agents Med Chem; 2016; 16(5):528-38. PubMed ID: 26234362
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.
Venza M; Visalli M; Catalano T; Biondo C; Beninati C; Teti D; Venza I
Oncol Rep; 2016 Apr; 35(4):2451-60. PubMed ID: 26883095
[TBL] [Abstract][Full Text] [Related]
30. A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis.
Onken MD; Worley LA; Harbour JW
Clin Cancer Res; 2008 Jun; 14(12):3737-45. PubMed ID: 18559591
[TBL] [Abstract][Full Text] [Related]
31. Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes.
Chiu KP; Ariyaratne P; Xu H; Tan A; Ng P; Liu ET; Ruan Y; Wei CL; Sung WK
BMC Cancer; 2007 Jun; 7():109. PubMed ID: 17594473
[TBL] [Abstract][Full Text] [Related]
32. Use of fluorescence in situ hybridization to distinguish metastatic uveal from cutaneous melanoma.
Fang Y; Wang X; Dusza S; Jhanwar S; Abramson D; Busam KJ
Int J Surg Pathol; 2012 Jun; 20(3):246-51. PubMed ID: 22415057
[TBL] [Abstract][Full Text] [Related]
33. The newest treatments for uveal melanoma.
Luke JJ
Clin Adv Hematol Oncol; 2019 Sep; 17(9):490-493. PubMed ID: 31549969
[No Abstract] [Full Text] [Related]
34. Focal adhesion kinase promotes the aggressive melanoma phenotype.
Hess AR; Postovit LM; Margaryan NV; Seftor EA; Schneider GB; Seftor RE; Nickoloff BJ; Hendrix MJ
Cancer Res; 2005 Nov; 65(21):9851-60. PubMed ID: 16267008
[TBL] [Abstract][Full Text] [Related]
35. Analysis of SDHD promoter mutations in various types of melanoma.
Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518
[TBL] [Abstract][Full Text] [Related]
36. Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2.
Yan D; Dong XD; Chen X; Yao S; Wang L; Wang J; Wang C; Hu DN; Qu J; Tu L
PLoS One; 2012; 7(7):e40967. PubMed ID: 22848417
[TBL] [Abstract][Full Text] [Related]
37. [Connection between uveal melanoma and dysplastic naevus syndrome].
Hammer H; Tóth-Molnár E; Oláh J; Dobozy A
Magy Onkol; 2005; 49(1):15-8. PubMed ID: 15902328
[TBL] [Abstract][Full Text] [Related]
38. Cell type identification from single-cell transcriptomes in melanoma.
Huo Q; Yin Y; Liu F; Ma Y; Wang L; Qin G
BMC Med Genomics; 2021 Nov; 14(Suppl 5):263. PubMed ID: 34784909
[TBL] [Abstract][Full Text] [Related]
39. DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients.
Venza M; Visalli M; Catalano T; Beninati C; Teti D; Venza I
Hum Pathol; 2017 Feb; 60():137-146. PubMed ID: 27825810
[TBL] [Abstract][Full Text] [Related]
40. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi.
Van Raamsdonk CD; Bezrookove V; Green G; Bauer J; Gaugler L; O'Brien JM; Simpson EM; Barsh GS; Bastian BC
Nature; 2009 Jan; 457(7229):599-602. PubMed ID: 19078957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
